Maker of ingredient in Labopharm's trazodone passes FDA inspection

10/7/2009 | Forbes

The FDA cleared a manufacturing plant owned by Angelini, maker of the active ingredient in Labopharm's once-daily version of antidepressant trazodone. The announcement could boost the chance of approval for Labopharm's product, which was delayed in July because of the manufacturing issue.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ